Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A National Health Service (NHS) hospital trust in the United Kingdom reduced home visits by using an AI-enabled wearable platform to remotely monitor patients recently released from the hospital, according to a case study.
AI for image analysis is predicted to be the top digital health technology for 2019 based on a survey of healthcare professionals, according to Forbes.
A patent application filed by Google indicates that the company is looking to develop an electronic health records (EHR) system that uses AI to predict a patient’s future medical events.
Researchers with MIT’s Computer Science and Artificial Intelligence Lab are working to develop an algorithm that can automatically “debias” data for AI models—an issue that has plagued the technology amid its growing prevalence in the medical field.
Telemedicine rates rose when temperatures plummeted during the polar vortex in late January, according to a report by WOOD-TV, local NBC affiliate in Grand Rapids, Michigan.
The nation’s third-largest nonprofit health system, Providence St. Joseph Health, has created a for-profit population health management company called Ayin Health Solutions.
An AI-based platform that prepares patients for total joint replacement surgery was associated with shorter hospital stays, according to a study published in the Annals of Translational Medicine.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.